Back to Journals » Therapeutics and Clinical Risk Management » Volume 5

Review

Role of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myeloma

       
Total article views   HTML views PDF downloads Totals
32,064 Dovepress* 32,064+ 1,895 33,959
Totals 32,064 1,895 33,959
*Since 22 January 2009
+Since July 2016

View citations on Google Scholar